Related Experiment Video
Updated: Feb 12, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Diabetes Mellitus and Cardiogenic Shock Complicating Acute Myocardial Infarction
Justin B Echouffo-Tcheugui1, Dhaval Kolte2, Sahil Khera3
1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
Insights
Diabetes increases the risk of acute myocardial infarction and cardiogenic shock. Diabetic patients with acute myocardial infarction and cardiogenic shock face higher mortality and longer hospital stays.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Diabetes mellitus is a known risk factor for acute myocardial infarction (AMI).
- The impact of diabetes on the incidence and outcomes of cardiogenic shock (CS) post-AMI is not well-established.
- Limited data exist on the relationship between diabetes and CS following AMI.
Purpose of the Study:
- To investigate the association between diabetes and the incidence of CS in patients hospitalized for AMI.
- To evaluate the impact of diabetes on the outcomes of patients experiencing CS after AMI.
- To analyze revascularization rates, in-hospital mortality, and post-discharge care among diabetic and non-diabetic CS patients.
Main Methods:
- Utilized data from the National Inpatient Sample (NIS) database from 2012-2014.
- Included adult patients (≥18 years) hospitalized for AMI.
- Employed multivariable logistic and linear regression models to assess associations.
Main Results:
- Diabetes was associated with a higher incidence of CS in AMI patients (5.8% vs. 5.2%).
- Diabetic patients with AMI and CS were less likely to receive revascularization procedures.
- Diabetes correlated with increased in-hospital mortality and longer hospital stays for CS survivors, with a higher likelihood of discharge to skilled nursing facilities.
Conclusions:
- Preexisting diabetes is linked to an elevated risk of developing CS following AMI.
- Diabetes negatively impacts the prognosis of patients with AMI complicated by CS.
- Healthcare strategies should consider the heightened risks and specific needs of diabetic patients experiencing AMI and CS.
Background:
Diabetes mellitus (diabetes) increases the risk of acute myocardial infarction, which can result in cardiogenic shock. Data on the relation of diabetes and the occurrence and prognosis of cardiogenic shock postacute myocardial infarction are scant.
Methods:
Among the National Inpatient Sample patients aged ≥18 years and hospitalized for acute myocardial infarction during the 2012-2014 period, we examined the association between diabetes and the incidence and outcomes of cardiogenic shock complicating acute myocardial infarction, using multivariable logistic and linear regression models.
Results:
Of 1,332,530 hospitalizations for acute myocardial infarction, 72,765 (5.5%) were complicated by cardiogenic shock. In acute myocardial infarction patients, cardiogenic shock incidence was higher among those with vs without diabetes (5.8% vs 5.2%; adjusted odds ratio [aOR] 1.14; 95% confidence interval [CI], 1.11-1.19; P < .001), with 42.8% (n = 31,135) of patients with acute myocardial infarction and cardiogenic shock having diabetes. Diabetic patients were less likely to undergo revascularization (percutaneous coronary intervention or coronary artery bypass grafting) (67.1% vs 68.7%; aOR 0.88; 95% CI, 0.80-0.96; P = .003). Diabetes was associated with higher in-hospital mortality in patients with acute myocardial infarction and cardiogenic shock (37.9% vs 36.8%; aOR 1.18; 95% CI, 1.09-1.28; P < .001). Among survivors, patients with diabetes had a longer hospital stay (mean ± SEM: 11.6 ± 0.16 vs 10.9 ± 0.16 days; adjusted estimate 1.12; 95% CI, 1.06-1.18; P < .001) and were more likely to be discharged to a skilled nursing home or with home health care (56.0% vs 50.5%; aOR 1.19; 95% CI, 1.07-1.33; P = .001).
Conclusions:
In a large cohort of acute myocardial infarction patients, preexisting diabetes was associated with an increased risk of cardiogenic shock and worse outcomes in those with cardiogenic shock.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Shock Waves
When the source's speed approaches the speed of sound, constructive interference between successive wavefronts emitted by the source occurs immediately behind it. Initially, scientists believed that this constructive interference would result in such high...
Hemodialysis II: Procedure and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

